Veracyte, Inc. Common Stock
VCYT
Jodie situation report
Veracyte, Inc. Common Stock's move is being confirmed by its market group.
VCYT accounts for 1.8% of the group's measured movement across 4.5 effective names. raw member direction is mixed; 0 of 10 session-normalized paths align to the mixed. Capital-flow agreement is 53%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
ADPT, MRNA, CORT moved materially before VCYT. VCYT crossed its material path threshold at 10:10 ET, 30 minutes after the first measured mover.
- Revenue increased 21.5% versus the comparable filing period.
5 of 10 members in Cancer Diagnostics are active. 0 of 8 disclosed connections are confirming.
- At least 7 of 10 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as MYGN begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.
Who this business touches
The relationships behind VCYT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CAICaris Life Sciences, Inc.competitorFeb 26, 2026 ▾
“As we expand our portfolio of tests, including into the MRD space, we may also face competition from companies informing treatment decisions such as Natera, Inc., Guardant Health, Inc., Exact Sciences Corporation, Personalis, Myriad Genetics, Neogenomics, Inc…”
DGXQuest Diagnostics IncorporatedcompetitorFeb 26, 2026 ▾
“As we expand our portfolio of tests, including into the MRD space, we may also face competition from companies informing treatment decisions such as Natera, Inc., Guardant Health, Inc., Exact Sciences Corporation, Personalis, Myriad Genetics, Neogenomics, Inc…”
Depended on by
PSNLPersonalis, Inc.competitorMay 7, 2026 ▾
“Some of our present or potential competitors, including Adela, Inc., Caris Life Sciences, Inc., DELFI Diagnostics, Inc., Exact Sciences Corporation, which was acquired by Abbott Laboratories, Inc., in March 2026, Foresight Diagnostics Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
VCYT is currently a Participant in the organic co-movement group Cancer Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.